Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: A new target to treat portal hypertension?

Journal of Hepatology

Volumn 43, Issue 5, 2005, Pages 791-798

  Sansoè, Giovanni ^a,d   Aragno, Manuela ^b   Mastrocola, Raffaella ^b   Restivo, Francesca ^b   Mengozzi, Giulio ^c   Smedile, Antonina ^b   Rosina, Floriano ^a   Danni, Oliviero ^b   Parola, Maurizio ^b   Rizzetto, Mario ^b  

^a GRADENIGO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Animal model; Atrial natriuretic peptide; Candoxatrilat; Liver cirrhosis; Liver myofibroblast like cells; Neutral endopeptidase; Portal pressure

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRADYKININ; CANDOXATRILAT; CARBON TETRACHLORIDE; CYCLIC GMP; DESMIN; ENDOTHELIN 1; ENKEPHALINASE INHIBITOR; GLUCOSE; INDOCYANINE GREEN; MEMBRANE METALLOENDOPEPTIDASE; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; HORMONE DETERMINATION; IMMUNOHISTOCHEMISTRY; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; MYOFIBROBLAST; NONHUMAN; PLASMA RENIN ACTIVITY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; STEADY STATE; URINARY EXCRETION;

ANIMALS; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARBON TETRACHLORIDE; CYCLIC GMP; CYCLOHEXANECARBOXYLIC ACIDS; CYTOKINES; ENDOTHELIN-1; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NEPRILYSIN; PORTAL VEIN; PROTEASE INHIBITORS; RATS; RATS, WISTAR; VASCULAR RESISTANCE;

EID: 26244439679     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.04.017     Document Type: Article

References (50)

1. R. Wiest, and R.J. Groszmann The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough Hepatology 35 2002 478 491
2. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N Engl J Med 339 1998 321 338
3. R. Brenard, R. Moreau, E. Pussard, B. Champigneulle, C. Gaudin, and A. Hadengue Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis J Hepatol 14 1992 347 356
4. H. Komeichi, R. Moreau, S. Cailmail, C. Gaudin, and D. Lebrec Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis J Hepatol 22 1995 319 325
5. R. Moreau, K.A. Tazi, H. Komeichi, E. Pussard, and D. Lebrec Hemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis Liver 20 2000 88 92
6. M. Ohsuga, R. Moreau, M. Hartleb, H. Komeichi, and D. Lebrec Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis J Hepatol 20 1994 91 96
7. P.G. Withrington, V.G. Dhume, R. Croxton, and A.L. Gerbes The actions of human atrial natriuretic factor on hepatic arterial and portal vascular beds of the anaesthetized dog Br J Pharmacol 99 1990 810 814
8. J. Tao, A. Mallat, C. Gallois, S. Belmadani, P.F. Mery, and J.T. Nhieu Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells J Biol Chem 274 1999 23761 23769
9. P. Weidmann, L. Hasler, M.P. Gnadinger, R.E. Lang, D.E. Uehlinger, and S. Shaw Blood levels and renal effects of atrial natriuretic peptide in normal man J Clin Invest 77 1986 734 742
10. J.J. Beutler, H.A. Koomans, T.J. Rabelink, C.A. Gaillard, J. Van Hattum, and P. Boer Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis Hepatology 10 1989 148 153
11. G. Laffi, M. Pinzani, E. Meacci, G. La Villa, D. Renzi, and E. Baldi Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites Gastroenterology 96 1989 167 177
12. R.M. Wilkins, I. Redondo, and L.A. Brown The natriuretic peptide family Lancet 349 1997 1307 1310
13. A.J. Kenny Regulatory peptide metabolism at cell surfaces: the key role of endopeptidase-24.11 Biomed Biochim Acta 45 1986 1503 1513
14. B. Malfroy, J.P. Swerts, A. Guyon, B.P. Roques, and J.C. Schwartz High-affinity enkephalin-degrading peptidase in brain is increased after morphine Nature 276 1978 523 526
15. P.A. Deddish, B.M. Marcic, F. Tan, H.L. Jackman, Z. Chen, and E.G. Erdos Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor Hypertension 39 2002 619 623
16. A.J. Cohen, T.E. King Jr, L.B. Gilman, C. Magill-Solc, and Y.E. Miller High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells Am J Respir Crit Care Med 158 1998 1593 1599
17. E.G. Erdos, and R.A. Skidgel Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones FASEB J 3 1989 145 151
18. J.P. Granger Inhibitors of ANF metabolism. Potential therapeutic agents in cardiovascular disease Circulation 82 1990 313 315
19. M. Haloui, D. Messika-Zeitoun, L. Louedec, M. Philippe, and J.B. Michel Potentiation of urinary atrial natriuretic peptide interferes with macula densa function Cardiovasc Res 51 2001 542 552
20. O. Lisy, M. Jougasaki, J.A. Schirger, H.H. Chen, P.T. Barclay, and J.C. Burnett Jr Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin Am J Physiol 275 1998 F410 F414
21. Z. Abassi, E. Golomb, and H.R. Keiser Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endhotelin Metabolism 41 1992 683 685
22. N. Lebel, P. D'Orleans-Juste, A. Fournier, and P. Sirois Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma Br J Pharmacol 117 1996 184 188
23. B receptors in the guinea pig perfused lung Clin Sci 103 2002 128S 131S
24. C.J. Ferro, J.C. Spratt, W.G. Haynes, and D.J. Webb Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo Circulation 97 1998 2323 2330
25. D.B. Northridge, A.G. Jardine, C.T. Alabaster, P.L. Barclay, J.M. Connell, and H.J. Dargie Effects of UK 69 578: a novel atriopeptidase inhibitor Lancet 2 1989 591 593
26. C. Gros, A. Souque, J.C. Schwartz, J. Duchier, A. Cournot, and P. Baumer Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan Proc Natl Acad Sci USA 86 1989 7580 7584
27. J.G. Motwani, C.C. Lang, G. Cramb, and A.D. Struthers Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men Hypertension 25 1995 637 642
28. T. Ogihara, H. Rakugi, K. Masuo, H. Yu, M. Nagano, and H. Mikami Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension Am J Hypertens 7 1994 943 947
29. B. Favrat, M. Burnier, J. Nussberger, J.M. Lecomte, R. Brouard, and B. Waeber Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension J Hypertens 13 1995 797 804
30. E. Proctor, and K. Chatamra High yield micronodular cirrhosis in the rat Gastroenterology 83 1982 1183 1190
31. S.L. Grainger, P.W.N. Keeling, I.M.H. Brown, J.H. Marigold, and R.P. Thompson Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man Clin Sci 64 1983 207 212
32. E. Burns, C.E. Ball, J.P. Christie, G.D. Broadhead, G.T. Tucker, and N.D. Bax Direct and indirect measurement of the hepatic extraction ratio of indocyanine green in the rat Clin Sci 76 1989 503 508
33. R. Molina, M. Sanchez, A. Hidalgo, and M.J.C. De Boto Influences of age and sex on endothelium-dependent vascular responses and arterial blood pressure in rat Gen Pharmac 25 1994 753 759
34. B. Civantos, and A. Aleixandre Blood pressure and α-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca Eur J Pharmacol 489 2004 101 110
35. 4 Nature 227 1970 685
36. M. Knecht, I. Pagel, T. Langenickel, S. Philipp, M. Scheuermann- Freestone, and T. Willnow Increased expression of neutral endopeptidase in severe heart failure Life Sci 71 2002 2701 2712
37. M. Parola, G. Leonarduzzi, G. Robino, E. Albano, G. Poli, and M.U. Dianzani On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis Free Radic Biol Med 20 1996 351 359
38. E. Zamara, E. Novo, F. Marra, A. Gentilini, R.G. Romanelli, and A. Caligiuri 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells J Hepatol 40 2004 60 68
39. M. Pinzani, and P. Gentilini Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis Semin Liver Dis 19 1999 397 410
40. P.S. Bhathal, and H.J. Grossmann Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators J Hepatol 1 1985 325 337
41. J. Reichen, and M. Le Verapamil favourably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver J Clin Invest 78 1986 448 455
42. P. Marteau, F. Ballet, O. Chazouilleres, Y. Chretien, C. Rey, and D. Petit Effects of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver Hepatology 9 1989 820 823
43. A. Kondepudi, and A. Johnson Cytokines increase neutral endopeptidase activity in lung fibroblasts Am J Respir Cell Mol Biol 8 1993 43 49
44. M. Letarte, S. Vera, R. Tran, J.B. Addis, R.J. Onizuka, and E.J. Quackenbush Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase J Exp Med 168 1988 1247 1253
45. T. Nakamura, R. Sakata, T. Ueno, M. Sata, and H. Ueno Inhibition of transforming growth factor-β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats Hepatology 32 2000 247 255
46. E. Olaso, and S.L. Friedman Molecular regulation of hepatic fibrogenesis J Hepatol 29 1998 836 847
47. K.S. Parks, Y. Li, Y. Zhang, A.L. Gerbes, H. Liu, and M.G. Swain Effects of neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats Br J Pharmacol 139 2003 81 88
48. J.C. Dussaule, J.D. Grangè, J.P. Wolf, J.M. Lecomte, C. Gros, and J.C. Schwartz Effect of sinorphan, an enkephalinase inhibitor, on plasma natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites J Clin Endocrinol Metab 72 1991 653 659
49. M.A. Newaz, Z. Yousefipour, H. Hercule, L. Truong, and A. Oyekan Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection Clin Exp Hypertens 25 2003 335 347
50. J.A. Grantham, J.A. Schirger, P.W. Wennberg, S. Sandberg, D.M. Heublein, and T. Subkowski Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis Circulation 101 2000 1976 1981